That said, humans who are homozygous or compound heterozygote for recessive MYO3A mutations suffer from non-syndromic hearing loss (DFNB30) that is progressive19, which suggests that substitution of MYO3B for MYO3A is not completely effective in the cochlea. The gene discussed is MYO3A; the disease is hearing loss disorder.